$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of revumenib-REVUFORJ market pricing, reference price range and formal drug purchase channels
2026-02-01 22:25:32
Check Details
The efficacy of inavolisib combined with palbociclib and fulvestrant
2026-02-01 22:25:32
Check Details
Can Datopotamab be used with other medicines?
2026-02-01 22:25:32
Check Details
The drug definition and principle of action of Mavakatai/Mefanto
2026-02-01 22:25:32
Check Details
Drug contraindications and usage recommendations for tenofovir alafenamide fumarate tablets (Vemlidy)
2026-02-01 22:25:32
Check Details
Recommended medication duration and treatment schedule for Lemborexant
2026-02-01 22:25:32
Check Details
Study the contraindications for drug combination of entacapone/codan
2026-02-01 22:25:32
Check Details
Recommended clinical usage and treatment course of Inavolisib
2026-02-01 22:25:32
Check Details
Adverse reactions and treatment methods of Datopotamab
2026-02-01 22:25:32
Check Details
2026 Mavacamten Capsule Price Comparative Study
2026-02-01 22:25:32
Check Details
Differences and connections between tenofovir alafenamide fumarate tablets (Vemlidy) and disoproxil
2026-02-01 22:25:32
Check Details
Lemborexant Instructions and Instructions for Use
2026-02-01 22:25:32
Check Details
1
2
...
2404
2405
2406
2407
2408
2409
2410
...
10229
10230
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Brensocatib for Non-Cystic Fibrosis Bronchiectasis: Patient Selection, ASPEN Data, and Safety Profile
2
Mirdametinib Mechanism and Clinical Guide: MEK Inhibitor for NF1 Plexiform Neurofibromas
3
FDA Approves Zanidatamab (Ziihera): HER2 Bispecific Antibody Plus Immunotherapy for First-Line Gastric Cancer
4
Acalabrutinib Dosing and Efficacy Guide: Administration, Response Evaluation, and Safety
5
Osimertinib Treatment and Dosing Guide: Efficacy, Administration, and Precautions
6
Bosutinib Indications Explained: CML Targeted Therapy and ADPKD Research Insights
7
Ceritinib Dosing Guide: 450mg Once Daily with Food – Key Administration Points
8
Ruxolitinib Drug Safety Guide: Drug Interactions, Hepatic/Renal Function, and Infection Risk Management
9
Revumenib Mechanism Explained: Targeting menin-KMT2A Interaction to Reshape Leukemia Cell Fate
10
Pretomanid Combination Therapy Safety Guide: BPaL Regimen Adverse Reaction Recognition and Monitoring
11
Asciminib (Scemblix): Targeted Mechanism, Dosing Regimens, and Missed-Dose Guidance
12
Vigabatrin (Sabril): Mechanism of Action, Pharmacokinetics, and Safety Monitoring